Defining a patient strategy for emerging markets

What is the best approach for defining patient services strategy for premium treatments in emerging, out-of-pocket markets?

Specialized “premium” therapy sales in growth markets is a strategic focus in the industry, and patient services offerings play an increasing role in achieving this goal. The development of patient programs in developing countries requires calibration to nuances of the local context, particularly for out-of-pocket markets.

What is the best approach for defining patient services strategy for premium treatments in emerging, out-of-pocket markets?

This white paper has been written by our consultants Kevin Maples and Francesca Schneller